Scholar Rock Holding Corp Logo

Scholar Rock Holding Corp

Biopharma developing medicines for neuromuscular diseases by targeting protein growth factors.

SRRK | US

Overview

Corporate Details

ISIN(s):
US80706P1030
LEI:
Country:
United States of America
Address:
301 BINNEY STREET, 2142 CAMBRIDGE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Scholar Rock Holding Corp. is a late-stage biopharmaceutical company focused on the discovery, development, and delivery of innovative medicines for serious diseases with high unmet medical needs, particularly neuromuscular diseases. The company's scientific approach utilizes a proprietary platform to selectively target protein growth factors before they are activated. This unique method aims to treat diseases by modulating key biological pathways at their source, contrasting with traditional approaches that address proteins after activation.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Scholar Rock Holding Corp filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Scholar Rock Holding Corp

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Scholar Rock Holding Corp via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Day One Biopharmaceuticals, Inc. Logo
Developing targeted cancer therapies for all ages, with a focus on pediatric oncology.
United States of America
DAWN
DBV Technologies S.A. Logo
Developing non-invasive skin patch immunotherapies for food allergies and immune diseases.
United States of America
DBVT
D&D Pharmatech Inc. Logo
Develops oral & injectable peptide therapies for metabolic & chronic diseases like obesity.
South Korea
347850
Dechra Pharmaceuticals PLC Logo
Develops & sells veterinary pharmaceuticals for companion animals, exclusively to veterinarians.
United Kingdom
DPH
Denali Therapeutics Inc. Logo
Developing therapies for neurodegenerative diseases that cross the blood-brain barrier.
United States of America
DNLI
Dermapharm Holding SE Logo
Manufactures patent-free branded pharmaceuticals & healthcare products for niche markets.
Germany
DMP
Dermata Therapeutics, Inc. Logo
Develops OTC skin treatments using a unique delivery technology from freshwater sponges.
United States of America
DRMA
Design Therapeutics, Inc. Logo
Develops small molecule genomic medicines to treat serious genetic diseases by modulating genes.
United States of America
DSGN
Deutsche Biotech Innovativ AG Logo
Develops biomarker-driven therapeutics and diagnostics for serious diseases with unmet needs.
Germany
DBI
DEVA HOLDİNG A.Ş. Logo
Global manufacturer of human/veterinary pharmaceuticals, APIs, and medical ampoules.
Spain
DEVA

Talk to a Data Expert

Have a question? We'll get back to you promptly.